[go: up one dir, main page]

ATE99952T1 - Verfahren zur behandlung von unfruchtbarkeit oder verminderter fruchtbarkeit bei erwachsenen maennern und die verwendung von praeparaten in diesem verfahren. - Google Patents

Verfahren zur behandlung von unfruchtbarkeit oder verminderter fruchtbarkeit bei erwachsenen maennern und die verwendung von praeparaten in diesem verfahren.

Info

Publication number
ATE99952T1
ATE99952T1 AT90912215T AT90912215T ATE99952T1 AT E99952 T1 ATE99952 T1 AT E99952T1 AT 90912215 T AT90912215 T AT 90912215T AT 90912215 T AT90912215 T AT 90912215T AT E99952 T1 ATE99952 T1 AT E99952T1
Authority
AT
Austria
Prior art keywords
pct
infertility
adult men
preparations
procedure
Prior art date
Application number
AT90912215T
Other languages
English (en)
Inventor
Niels Erik Skakkebaek
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE99952T1 publication Critical patent/ATE99952T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT90912215T 1989-07-28 1990-07-27 Verfahren zur behandlung von unfruchtbarkeit oder verminderter fruchtbarkeit bei erwachsenen maennern und die verwendung von praeparaten in diesem verfahren. ATE99952T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK372589A DK372589D0 (da) 1989-07-28 1989-07-28 Protein
PCT/DK1990/000194 WO1991001747A1 (en) 1989-07-28 1990-07-27 Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method.

Publications (1)

Publication Number Publication Date
ATE99952T1 true ATE99952T1 (de) 1994-01-15

Family

ID=8126083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912215T ATE99952T1 (de) 1989-07-28 1990-07-27 Verfahren zur behandlung von unfruchtbarkeit oder verminderter fruchtbarkeit bei erwachsenen maennern und die verwendung von praeparaten in diesem verfahren.

Country Status (9)

Country Link
US (1) US5250514A (de)
EP (1) EP0484429B1 (de)
JP (1) JPH04506969A (de)
AT (1) ATE99952T1 (de)
AU (1) AU639013B2 (de)
CA (1) CA2064023A1 (de)
DE (1) DE69006032T2 (de)
DK (2) DK372589D0 (de)
WO (1) WO1991001747A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137219C (en) * 1994-12-02 1997-10-21 Salva Gideon Extract for improving male sperm count and use as anti-microbial or anti-inflammatory agent
EP1149583A3 (de) * 2000-04-13 2001-11-14 Pfizer Products Inc. Kombinationen bestehend aus Antagonisten des Corticotropin freisetzenden Faktors und Stoffen, die die Wachstumshormonsekretion fördern

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
HU193093B (en) * 1985-04-16 1987-08-28 Innofinance Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
DE3518252A1 (de) * 1985-05-21 1986-11-27 Dirck Dr.med. 6500 Mainz Oppermann Nasal zu applizierendes mittel zur bekaempfung maennlicher und weiblicher infertilitaet
AU607410B2 (en) * 1986-01-09 1991-03-07 Brigham And Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US4816439A (en) * 1987-03-27 1989-03-28 Nordiske Gentofte A/S The use of human growth hormone for the treatment of intoxicated individuals
US5017557A (en) * 1987-07-24 1991-05-21 Industria Farmaceutica Serono S.P.A. Treatment of infertility with somatotrophin releasing factor
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation

Also Published As

Publication number Publication date
JPH04506969A (ja) 1992-12-03
CA2064023A1 (en) 1991-01-29
AU639013B2 (en) 1993-07-15
DE69006032T2 (de) 1994-05-05
DK0484429T3 (da) 1994-05-02
WO1991001747A1 (en) 1991-02-21
DE69006032D1 (de) 1994-02-24
EP0484429B1 (de) 1994-01-12
EP0484429A1 (de) 1992-05-13
US5250514A (en) 1993-10-05
DK372589D0 (da) 1989-07-28
AU6163690A (en) 1991-03-11

Similar Documents

Publication Publication Date Title
IL154797A0 (en) Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium
ATE184776T1 (de) Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
ATE248922T1 (de) Hormonanaloge mit mehreren ctp-erweiterungen
ATE104854T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose.
Beyer et al. Sexual behavior in pregnant and lactating domestic rabbits
DE69528751D1 (de) Verwendung von Interferon-alpha 8 subtype zur Herstellung von Medikamenten zur Behandlung von Viralinfektionen der Leber
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
ATE104551T1 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
ATE190499T1 (de) Methode zur behandlung von reproduktionserkrankungen
DE3872614D1 (de) Verfahren zur behandlung der unfruchtbarkeit und mittel zur verwendung dabei.
GR3030947T3 (en) Selective system scan for multizone radiotelephone subscriber units.
Warnock 'The good of the child'
ATE99952T1 (de) Verfahren zur behandlung von unfruchtbarkeit oder verminderter fruchtbarkeit bei erwachsenen maennern und die verwendung von praeparaten in diesem verfahren.
DE69326122D1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
ATE141512T1 (de) Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE69131629D1 (de) Behandlung fehlender milchabsonderung beim menschen
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE197764T1 (de) Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.
Heim Effects of surgery and autologous tissue implantation on liver catalase activity of the mouse
UA7163A (uk) Спосіб відновлення ушкоджених тканин людини чи тварини

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee